Investigational Drug Information for Chidamide
✉ Email this page to a colleague
What is the development status for investigational drug Chidamide?
Chidamide is an investigational drug.
There have been 156 clinical trials for Chidamide.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2019.
The most common disease conditions in clinical trials are Lymphoma, Lymphoma, T-Cell, and Lymphoma, T-Cell, Peripheral. The leading clinical trial sponsors are Sun Yat-sen University, Chinese PLA General Hospital, and Chipscreen Biosciences, Ltd.
There are five US patents protecting this investigational drug and twenty-eight international patents.
Summary for Chidamide
| US Patents | 5 |
| International Patents | 28 |
| US Patent Applications | 40 |
| WIPO Patent Applications | 40 |
| Japanese Patent Applications | 10 |
| Clinical Trial Progress | Phase 2 (2019-09-01) |
| Vendors | 52 |
Recent Clinical Trials for Chidamide
| Title | Sponsor | Phase |
|---|---|---|
| SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Tucidinostat Plus Apatinib for Advanced Osteosarcoma | Wuhan Union Hospital, China | Phase 2 |
| Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma | Dongguan People's Hospital | Phase 2 |
Clinical Trial Summary for Chidamide
Top disease conditions for Chidamide
Top clinical trial sponsors for Chidamide
US Patents for Chidamide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Chidamide | ⤷ Sign Up | 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors | Shenzhen Chipscreen Biosciences Ltd. (Shenzhen, CN) | ⤷ Sign Up |
| Chidamide | ⤷ Sign Up | Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors | Shenzhen Chipscreen Biosciences Ltd. (Shenzhen, CN) | ⤷ Sign Up |
| Chidamide | ⤷ Sign Up | Histone deacetylase inhibitors | Orchid Chemicals & Pharmaceuticals Limited (Chennai, IN) | ⤷ Sign Up |
| Chidamide | ⤷ Sign Up | Crystal form of chidamide, preparation method and use thereof | SHENZHEN CHIPSCREEN BIOSCIENCES, LTD. (Shenzhen, Guangdong, CN) | ⤷ Sign Up |
| Chidamide | ⤷ Sign Up | Agents for killing HIV-1-infected cells and application thereof | KAGOSHIMA UNIVERSITY (Kogoshima-Shi, Kagoshima, JP) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Chidamide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Chidamide | Australia | AU2008309269 | 1989-12-31 | ⤷ Sign Up |
| Chidamide | Canada | CA2702536 | 1989-12-31 | ⤷ Sign Up |
| Chidamide | European Patent Office | EP2205563 | 1989-12-31 | ⤷ Sign Up |
| Chidamide | Japan | JP2011501746 | 1989-12-31 | ⤷ Sign Up |
| Chidamide | Japan | JP2014144947 | 1989-12-31 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
